Octagon Capital Advisors’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-666,825
| Closed | -$1.14M | – | 39 |
|
|
2024
Q3 | $1.14M | Sell |
666,825
-666,825
| -50% | -$1.14M | 0.18% | 35 |
|
|
2024
Q2 | $3.4M | Buy |
1,333,650
+793,650
| +147% | +$2.02M | 0.53% | 30 |
|
|
2024
Q1 | $2.26M | Buy |
+540,000
| New | +$2.26M | 0.27% | 52 |
|
|
2023
Q1 | – | Sell |
-45,000
| Closed | -$231K | – | 37 |
|
|
2022
Q4 | $231K | Sell |
45,000
-179,300
| -80% | -$920K | 0.04% | 32 |
|
|
2022
Q3 | $2.22M | Sell |
224,300
-35,700
| -14% | -$353K | 0.38% | 29 |
|
|
2022
Q2 | $2.18M | Sell |
260,000
-398,266
| -61% | -$3.35M | 0.58% | 18 |
|
|
2022
Q1 | $8.29M | Sell |
658,266
-44,357
| -6% | -$558K | 1.79% | 15 |
|
|
2021
Q4 | $11.1M | Buy |
702,623
+100,000
| +17% | +$1.59M | 2.17% | 13 |
|
|
2021
Q3 | $15.2M | Buy |
602,623
+199,100
| +49% | +$5.01M | 3.73% | 9 |
|
|
2021
Q2 | $11.8M | Buy |
+403,523
| New | +$11.8M | 2.45% | 13 |
|